Related by context. Frequent words. (Click for all words.) 61 phase IIb 59 phase IIa 56 dose cohorts 56 Phase 1b clinical 55 Phase IIb clinical 55 Phase IIb 55 Phase 2b 54 Phase IIa trial 54 Phase 2b clinical 54 multicenter clinical 53 dose regimens 53 Phase 1a 52 Phase IIa clinical 52 Phase 2b study 52 phase 2a 52 Phase Ib 51 pivotal Phase III 51 Phase 2a clinical 51 Phase 2a trial 51 Phase 1b trial 51 Phase III clinical trials 51 Phase IIb trial 51 Phase III clinical 50 Phase 2b trial 50 confirmatory Phase III 50 teduglutide 50 secondary efficacy endpoints 50 active comparator 50 multicenter randomized double 50 Phase III 50 dose escalation trial 50 Phase III trials 49 clinical trials 49 Phase IIa 49 Phase 1b 49 Phase II 49 dosing regimens 49 axitinib 49 confirmatory Phase 3 49 eniluracil 48 pivotal Phase 48 placebo controlled randomized 48 Phase IIa clinical trials 48 clinical endpoints 48 randomized controlled clinical 48 Phase 2a 48 Phase III randomized 48 IMGN# 48 Phase Ia 48 randomized Phase III 48 IND enabling 48 double blind placebo 48 safety tolerability pharmacokinetics 47 clinical trial 47 MOZOBIL 47 safety tolerability 47 Phase III pivotal 47 pharmacokinetic studies 47 IMC A# 47 randomized Phase 47 TELCYTA 47 label dose escalation 47 HspE7 47 multicentre 46 nab paclitaxel 46 sapacitabine 46 Phase 46 subgroup analyzes 46 tesmilifene 46 ofatumumab 46 blinded placebo controlled 46 blind randomized placebo 46 blind randomized controlled 46 pharmacokinetic 46 randomized placebo controlled 46 ProLindac 46 Secondary endpoints 46 valopicitabine 46 INCB# [002] 45 prospective randomized controlled 45 blinatumomab 45 placebo controlled studies 45 randomized double 45 ozarelix 45 multiple ascending dose 45 tesetaxel 45 romidepsin 45 PF # [001] 45 Ostarine 45 MAP# 45 prospective observational 45 drug conjugate 44 Amigal 44 IV melanoma 44 multicenter randomized 44 Reolysin 44 ocrelizumab 44 preclinical 44 placebo controlled trials 44 HGS ETR1 44 taspoglutide